Showing results (161-170 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|May 13, 2020
Factors Associated with Declining to Participate in a Pediatric Oncology Next Generation Sequencing StudyKatianne M Howard Sharp, Niki Jurbergs, Annastasia Ouma, et al.
JCO Precision Oncology|August 24, 2022
Bayesian Sample Size Planning Tool for Phase I Dose-Finding TrialsXiaolei Lin, Jiaying Lyu, Shijie Yuan, et al.
JCO Precision Oncology|November 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National CohortManon Girod, Stéphane Dalle, Laurent Mortier, et al.
JCO Precision Oncology|November 10, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver MetastasesFederica Marmorino, Michele Prisciandaro, Mirella Giordano, et al.
JCO Precision Oncology|November 29, 2022
Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry PopulationsJessica W Chen, Karthikeyan Murugesan, Justin Y Newberg, et al.
JCO Precision Oncology|November 29, 2022
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood CancerLorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, et al.
JCO Precision Oncology|June 7, 2021
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With RhabdomyosarcomaJung Kim, Nicholas Light, Vallijah Subasri, et al.
JCO Precision Oncology|January 5, 2023
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung CancerRohan R Katipally, Liam F Spurr, Stanley I Gutiontov, et al.
JCO Precision Oncology|January 12, 2023
Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel TestingShelly Cummings, Andrew Alfonso, Elisha Hughes, et al.
JCO Precision Oncology|January 18, 2023
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric RhabdomyosarcomaNathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter, et al.
Pageof 140